GRAIL, Inc. (GRAL) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for GRAIL, Inc. (GRAL).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $33.00

Daily Change: -$0.0808 / 0.24%

Daily Range: $31.75 - $33.64

Market Cap: $1,190,004,224

Daily Volume: 697,489

Performance Metrics

1 Week: -3.65%

1 Month: -21.77%

3 Months: -5.04%

6 Months: -4.16%

1 Year: 92.30%

YTD: 84.65%

Company Details

Employees: 1000

Sector: Health technology

Industry: Medical specialties

Country:

Details

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Selected stocks

Zynex, Inc. (ZYXI)

Bioventus Inc. (BVS)

Stryker Corporation (SYK)